Harbin Clinic Oncologists named Lead GA NCORP Investigators for Cancer Care

Two Harbin Clinic Medical Oncologists are making positive waves in the field of clinical cancer research.

Dr. Melissa Dillmon and Dr. Dilawar Khan of the Harbin Clinic Tony E. Warren Cancer Center have each been recognized on a national and state level for the number of patients they enrolled in clinical trials for cancer research during 2016 and 2017. 

For trial-eligible patients, they were able to procure the highest level of cancer care through a five-year grant awarded by the National Cancer Institute to the Georgia Center for Oncology, Research and Education (CORE) of which Harbin Clinic is an affiliate. 

As part of the NCI’s national network of private and public cancer caregivers known as NCORP, Drs. Dillmon and Khan were named Lead GA NCORP Investigators for their tireless efforts for cancer research.

Cutting-Edge Treatment at Harbin Clinic Cancer Center

From 2016-2017, Dr. Dillmon enrolled 13 patients in clinical trials and Dr. Khan enrolled eight, each placing in the Top Accruing Investigators in Georgia.

“At Harbin Clinic, we are practicing the highest level of medical science, delivering top-quality care to our patients,” says Dr. Dillmon. “Through the NCORP grant, we’re able to bring cutting-edge trials to a community setting.”

This is the third year the NCORP grant has allowed the latest cancer treatments to be available for Harbin Clinic Cancer Center patients. Participating in clinical trials through the grant allows patients to receive top-notch care in close proximity to their support systems, says Dr. Dillmon.

“Instead traveling far distances - to Emory, Vanderbilt or UAB -  our patients can stay closer to home and receive the same level of care they would at a larger institution,” Dr. Dillmon explains. “That way, they’re easily supported by their family and friends while they’re going through treatment.”

Throughout the past year, Drs. Dillmon and Khan enrolled cancer patients in studies that are part of nationwide efforts looking at new treatment options and targeted therapies. The aim of the NCORP grant is to develop the most effective strategies to prevent, diagnose and treat cancer.

Both Dr. Khan and Dr. Dillmon say their participation in NCORP helps them stay on top of the game when it comes to breakthrough therapies.

“Cancer treatment options are constantly evolving,” says Dr. Khan. “Through our research, we’re actively engaged in the science of clinical breakthroughs, which is immensely beneficial to our patients at the Harbin Clinic Cancer Center.”

“Because of the nature of our work, we’re scientists in some way or fashion,” echoes Dr. Dillmon. “Having patients in these trials helps us continue to keep our practices up-to-date with the latest treatments.”

About the Harbin Clinic Tony E. Warren Cancer Center

The Harbin Clinic Tony E. Warren Cancer Center is a state-of-the-art facility housing the top cancer care experts in Northwest Georgia.

A hub for all cancer care needs, Harbin Clinic provides prevention, detection, diagnosis, cancer education and anti-cancer treatments that include surgery, radiation and chemotherapy. By providing support through complementary, integrative therapies and survivorship, Harbin Clinic cares completely for the whole person throughout their cancer journey.

Harbin Clinic is Georgia’s largest physician-owned, multispecialty clinic with more than 240 medical professionals representing 40 specialties and services. While Harbin Clinic began in Rome, Ga., there are now 21 Harbin Clinic practices located in Acworth, Adairsville, Armuchee, Calhoun, Cartersville, Cedartown, Rome and Summerville.